Hepatorenal Syndrome Treatment in the US Today  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA

​

Review of Eosinophilic Esophagitis  • Seyedehsan Navabi, MD

​

New Treatment Innovations in Ulcerative Colitis and Crohn’s Disease  • Stephen B. Hanauer, MD

​

New Advances in NASH in 2022  • David Kaplan, MD

​

Indeterminate Colitis: How to Approach?  • Farzana Rashid, MD

​

How to Increase the Adenoma Detection Rate  • Sushil Ahlawat, MD

​

New Advances Distinguished Lecturer 2022: Viral Hepatitis Elimination  • Rajender Reddy, MD

 

Hepatitis B Cure: New Drugs, Novel Strategies  • Jordan Feld, MD, MPH

​

Hepatitis C: What’s New? Is There Any Difficult to Treat Populations Nowadays?  • Kimberly Brown, MD

​

Maximizing the Donor Potential for Liver Transplant  • James Guarrera, MD

​

Minimally Invasive vs. Surgical Bariatric Interventions. Winner?  • Kaveh Hajifathalian, MD

 

Advances in Pancreaticobiliary Endoscopy: Creating Alternate Solutions  • Georgios Papachristou, MDH

​

Gastroparesis: Are We Moving on This Today?  • Anthony J. Lembo, MD

​

NASH: Diagnostic and Prognostic Non-Invasive Tests  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA

​

Irritable Bowel Syndrome: New Management Approaches  • Anthony J. Lembo, MD

​

Cirrhotic Cardiomyopathy: Does It Exist?  • Marc Klapholz, MD

 

Liver Cancer: Still on the Rise or Plateaued?  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA

​

Hepatic Encephalopathy Overview  • Paul Martin, MD

​

Wilson’s Disease: New Guidelines?  • Nancy Reau, MD

​

Heartburn/GERD and H. Pylori  • Ronnie Fass, MD

​

Alcoholic Liver Disease and COVID  • Paul Martin, MD

​

Hemochromatosis: Is It the Liver’s Heavy Metal?  • Nancy Reau, MD

​

C Difficult…  • Sahil Khanna, MD

​